The Medicare health plan said on Tuesday that newly negotiated prices for 15 of its costliest drugs will save 36% on those ...

Pharmacy benefit managers (PBMs) are back in the crosshairs. PBMs negotiate drug prices down on behalf of consumers and insurers – to the ire of ...

Eli Lilly will cut prices for its weight loss drug Zepbound, with single-dose vials now available for $299 per month through ...

The Trump administration late Tuesday announced new lower Medicare prices for 15 drugs that were part of the latest round of ...

Medicare has locked in lower prices on a slate of heavily used prescription drugs, a shift that will ripple through household ...

Medicare announced 15 lower drugs after a second round of negotiations with pharmaceutical companies. The drugs include Ozempic and also drugs to treat asthma, breast cancer and leukemia.

Medicare will save approximately $12 billion, or 44%, on 15 high-cost medications as a result of the second round of the ...

Discover how new U.S. Medicare drug price cuts impact major pharma stocks like Novo Nordisk and why sector resilience ...

The federal government has announced 15 more drugs, including Ozempic and Wegovy, that will have lower negotiated prices for Medicare beneficiaries starting in 2027.

If you purchase an independently reviewed product or service through a link on our website, Rolling Stone may receive an affiliate commission. We have Amazon to thank (or blame) for completely ...

Medicare will announce negotiated prices for 15 high-cost drugs, impacting over 67 million beneficiaries. The Inflation ...

Negotiations are expected to continue in future cycles as part of President Donald Trump's "aggressive push for lower prices.